I’ve never seen anyone refer to EXAS as a scam; however, it’s reasonable to consider the degree to which the USPSTF guidelines will impede the uptake of Cologuard reimbursement by US private payers.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”